Every year since 2014, the business magazine Challenges has singled out the “100 startups to invest in”.
A true benchmark for investors, this ranking welcomes Hemerion for the first time this year, in the Medtech / Biotech category.
“Les 100 startups où investir” is an annual ranking carried out since 2014 by the French business magazine “Challenges”. The ranking aims to identify the most promising young innovative companies in France. The ranking covers the Greentech, Medtech, Deeptech, Software & AI, Fintech and Ecommerce sectors.
Selected startups are evaluated according to several criteria, including their growth potential, business model, management team, level of innovation and ability to raise funds. This ranking is considered a benchmark for investors in France.
The ranking has welcomed many healthcare companies that have become major players in their markets, such as Doctolib and Withings.
Launched in 2020, Hemerion features in this year’s Medtech / Biotech ranking, alongside 15 other French startups.